Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (14584)	11/17/1999 5:20:00 PM
From: SSP	Read Replies (1) \| Respond to of 150070

Nov. 17, 1999--Loch Harris Inc. (OTC BB:LOCH) announced today that Lucent and Loch's subsidiary ChemTech have executed a 3 year mutually binding non disclosure agreement today, following Dr. Henry Blair's presentation at Lucent's international teleconference. Rodney Boone, CEO of both Loch and ChemTech said, "Private talks were held with Lucent specialists from a variety of semiconductor disciplines." The conference and presentations were held at Lucent's semiconductor processing facility in Orlando, Fla. "This relationship will provide ChemTech with a meaningful mechanism to explore and test a variety of opportunities for direct application of the proprietary VAMMP semiconductor technology," according to ChemTech's renowned physicist, Dr. Henry Blair. VAMMP, the multi-constituent monitor of plasma is capable of providing precise, non-invasive monitoring of vacuum processes and contaminants in real-time. Boone stated, "We believe that today's discussions will result in a long-term intellectual partnership with Lucent and Bell Laboratories." During Dr. Blair's presentation, he also released hard data from last week's successful high-explosive affluent-only test of VAMMP's sister technology for landmine identification and mapping. Follow-up meetings with Lucent are scheduled to identify timelines for future development and research of VAMMP. VAMMP is fully funded and scheduled for bench tests by March 2000. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, regulatory approval processes, the impact of competitive products or other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. --30--csd/sa* CONTACT: Loch Harris Inc., Austin Investor Relations, 512/328-7808 lochharris.com